Skip to content
SEKISUI XenoTech DD Blog Logo

SEKISUI XenoTech Adds New Drug Transporters to Portfolio

Transporters have become increasingly important in drug development due to the major role they play in absorption, distribution and excretion of endogenous and exogenous compounds. The FDA, EMA and PMDA emphasize the importance of evaluating new drug candidates for transporter-mediated drug-drug interactions (DDI) with a determination of substrate and inhibition potential.

SEKISUI XenoTech features the most extensive selection of drug transporters and assays available in the world. Our Drug Transport Research Services include the full range of FDA/EMA required drug transporters as well as less common transporters that may also play an important role for your compounds. Newly added transporters include ENT4, CNT1, CNT2, CNT3, GLUT1 and GLUT2. View our full Portfolio of Available Drug Transporter Assays.

If you are performing your own research, we also offer multiple test systems for the major drug transporters, including transporter-certified and numerous other hepatocytes, to determine if compounds are substrates or inhibitors of clinically-relevant transporters. View our Guide to Selecting In Vitro Test Systems for guidance on which is the best choice for your studies.

Learn more about:

About the Authors

Michael Millhollen received his bachelor's degree in Visual Communications from the University of Kansas and has over 20 years of experience in marketing and communications. As Global Marketing Manager, he is dedicated to the objective of sharing SEKISUI XenoTech’s scientific expertise and knowledge with scientists around the world.

Subscribe to our Newsletter

Stay up to date with our news, events and research

In vitro pipette test article treatment
005 International Messaging Created with Sketch.

Do you have a question or a request for upcoming blog content?

We love to get your feedback

A scientist utlilizing a microplate